Bruxism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Volunteers of both sexes; between 18 and 40 years of age; with a diagnosis of problable bruxism that will be based in the presence of a positive result in the self-report and clinical odontological inspetion
Exclusion criteria
Exclusion criteria: Participants under the age of 18; who do not agree to participate in this study or who have cognitive deficit determined by the MMSE questionnaire - Mini Mental State Examination; hearing deficit that prevents understanding of verbal instructions; neuromuscular disorders and/or trauma-orthopedic conditions that prevent the participant from carrying out the assessments and/or proposed intervention; pregnant or lactating women; individuals diagnosed with cancer and autoimmune diseases; present other associated osteoarticular disorders at the application site; have severe symptoms of depressive disorders and/or anxiety disorders, alcohol and/or drug abuse; daily use of pain control medication (as preventive medication for the treatment of chronic tension headache and/or migraine); present tooth loss of more than two posterior teeth, except third molars; who are on concomitant treatment for bruxism; users of occlusal splints, complete dentures, removable partial dentures and orthodontic appliances; who have not taken at least the first dose of the Covid-19 vaccine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-reported bruxism score on a 5-point Likert scale (never, rarely, sometimes, frequently and continuously) and evaluation of pain using Visual Analog Scale (EVA) and algometry (portion of the sternal portion of the sternocleidomastoid muscle and the superficial muscle fibers of the trapezius muscle) evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of mandibular functionality limitation using the Mandibular Functional Limitation Questionnaire and Index (MIFQ) and the Jaw Functional Limitation Scale (JFLS-20). It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of mandibular opening evaluated by the maximum mouth opening measured by digital caliper, being considered limited to opening with a value of less than 40 mm. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of harmful oral behaviors during sleep and wakefulness using the Oral Behavior Checklist (OBC). It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of sleep quality using the Pittsburgh Sleep Quality Index (PSQI). It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of the perception of stress through the Stress Perception Scale. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Assessment of anxiety by the Generalized Anxiety Disorders and Anxiety Questionnaire (GAD-7) and of depression by the Depression Symptoms Severity Questionnaire (Patient Health Questionnaire PHQ-9. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up.;Satisfaction with electromassage through a resource satisfaction questionnaire on a 5-point Likert scale. It will be evaluated before the first intervention, after the fourth and last application and, finally, after the 1-month follow-up. | — |
Countries
Brazil
Contacts
Universidade Federal do Paraná